| Line Item | 2025-10-03 | Y/Y |
|---|---|---|
| Revenue | $967.3M | +32.6% |
| Cost of Revenue | $438.3M | +30.5% |
| Gross Profit | $529.0M | +34.3% |
| R&D Expense | $244.5M | +34.2% |
| SG&A Expense | $154.9M | +12.3% |
| Operating Income | $129.7M | +76.0% |
| Pre-tax Income | -$29.0M | -131.7% |
| Income Tax | $25.2M | +71.7% |
| Net Income | -$54.2M |
| Line Item | 2025-10-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.1M | -23.6% |
| Short-term Investments | $673.8M | +54.9% |
| Accounts Receivable | $148.6M | +40.6% |
| Inventory | $237.8M | +22.3% |
| Current Assets | $1.21B | +33.4% |
| Total Assets | $2.10B | +19.8% |
| Current Liabilities | $325.1M | +200.5% |
| Line Item | 2025-10-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $235.4M | +44.7% |
| Capital Expenditures | $42.6M | +89.6% |
| Investing Cash Flow | -$328.3M | -81.2% |
| Financing Cash Flow | $58.1M | +741.0% |
| Free Cash Flow | $192.8M | +37.5% |
| -170.5% |
| EPS (Basic) | -$0.73 | -168.2% |
| EPS (Diluted) | -$0.73 | -170.2% |
| Long-term Debt |
| $339.6M |
| -24.2% |
| Total Liabilities | $776.3M | +23.4% |
| Stockholders' Equity | $1.33B | +17.8% |